More Data, Fewer Antibiotics Are Keys to Fighting Deadly Superbugs
As our lawmakers in the Senate discuss the fees that companies will pay to help the FDA expedite drug reviews, they should also require those companies to provide information that helps the agency protect people from drug-resistant superbugs.
data fewer antibiotics keys fight deadly superb USA lawmaker senate disc USA fee company pay help fda expedite drug review require company provide information help agency protect people drug resistant superbug